chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: About 3 days after getting the vaccine, I got chills, body ache, severe headache and my fever spiked to 102.4
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Headache, Pain, Pyrexia
Clinical narrative: About 3 days after getting the vaccine, I got chills, body ache, severe headache and my fever spiked to 102.4
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Glossitis, Lip swelling, Swollen tongue
Clinical narrative: Inflammation under my tongue and on my tongue.  Swelling under my tongue swelling  on my lips (upper and below)
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus disorder, Swelling face
Clinical narrative: Bilateral facial/sinus swelling
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest discomfort, Chest pain, Dizziness, Dyspnoea
Clinical narrative: Chest and neck tightness/pain, shortness of breath, dizziness, ears ringing, vision spotty followed by sweating and weakness.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Muscle tightness, Neck pain, Tinnitus, Visual impairment
Clinical narrative: Chest and neck tightness/pain, shortness of breath, dizziness, ears ringing, vision spotty followed by sweating and weakness.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Headache, Pain in extremity
Clinical narrative: sore arm, severe headache, dizziness upon standing, diarrhea
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Pain
Clinical narrative: mild headache all day after vaccine, fatigue and body aches starting around 12 hours after vaccine Chills around 14 hours post vaccine (still very achy and fatigued) - went to sleep woke up within 3 hours with a fever and sweats - drank water and went back to sleep with ice packs woke up about 3 hours later with the chills again, but broke the fever by 24 hours post vaccine, all was relatively normal again, mild headache still and tired from poor sleep
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: mild headache all day after vaccine, fatigue and body aches starting around 12 hours after vaccine Chills around 14 hours post vaccine (still very achy and fatigued) - went to sleep woke up within 3 hours with a fever and sweats - drank water and went back to sleep with ice packs woke up about 3 hours later with the chills again, but broke the fever by 24 hours post vaccine, all was relatively normal again, mild headache still and tired from poor sleep
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Decreased appetite, Dizziness, Fatigue
Clinical narrative: chills; slight temperature; body aches; headache; dizziness; extreme fatigue; no appetite; very sleepy; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 71-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot Number: UNKNOWN) via an unspecified route of administration, administered in Arm Left on 08Feb2021 13:30 (at the age of 71-year-old) as single dose for COVID-19 immunization. The patient medical history was not reported. No chronic health conditions were reported for patient. Concomitant medications included daily calcium and vitamin pill. The patient previously took ciprofloxacin and experienced drug hypersensitivity, historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot Number: UNKNOWN) via an unspecified route of administration, administered in Arm Left on on 18Jan2021 at 02:00 pm (at the age of 71-year-old) as single dose for COVID-19 immunization. On 08Feb2021 at 11:45Pm, the patient reported that he had these symptoms for the 2 days following vaccine included chills, slight temperature, body aches, headache, dizziness, extreme fatigue, no appetite and was very sleepy. It was reported that patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior or post to the vaccination. Patient did not receive any treatment for the events. Events were considered non-serious as reported. Patient was recovered with sequelae form all the events.  Information regarding Batch/ Lot number have been requested
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia, Somnolence
Clinical narrative: chills; slight temperature; body aches; headache; dizziness; extreme fatigue; no appetite; very sleepy; This is a spontaneous report from a contactable consumer. This consumer reported for herself that a 71-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot Number: UNKNOWN) via an unspecified route of administration, administered in Arm Left on 08Feb2021 13:30 (at the age of 71-year-old) as single dose for COVID-19 immunization. The patient medical history was not reported. No chronic health conditions were reported for patient. Concomitant medications included daily calcium and vitamin pill. The patient previously took ciprofloxacin and experienced drug hypersensitivity, historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot Number: UNKNOWN) via an unspecified route of administration, administered in Arm Left on on 18Jan2021 at 02:00 pm (at the age of 71-year-old) as single dose for COVID-19 immunization. On 08Feb2021 at 11:45Pm, the patient reported that he had these symptoms for the 2 days following vaccine included chills, slight temperature, body aches, headache, dizziness, extreme fatigue, no appetite and was very sleepy. It was reported that patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior or post to the vaccination. Patient did not receive any treatment for the events. Events were considered non-serious as reported. Patient was recovered with sequelae form all the events.  Information regarding Batch/ Lot number have been requested
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Fever of 100.8; chills; headache; This is a spontaneous report from a contactable consumer (patient sister). A 66-year-old female patient received BNT162B2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) second dose via unspecified route of administration, administered in left arm on 02Feb2021 13:30 and first dose via unspecified route of administration, administered in left arm on 12Jan2021 3:00 PM as single dose for COVID-19 immunization. The patient medical history included prior breast cancer. The patient concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, patient had not tested for COVID-19. Patient does not for underwent lab test and procedures which included COVID-19 test for post vaccination. On 10Feb2021 03:00 PM patient experienced Fever of 100.8, chills, headache. This report was for reporter's sister who received the second dose of the Pfizer COVID vaccine. The reporter reported it on the day she told me about it also reported that within 24 hours of learning of her reaction as required under our reporting policy. The outcome of the events was recovered.  Follow-up (19-Feb2021): This is a follow-up spontaneous report in response to mail trail sent regarding confirmation of reporter and awareness date. This report included the awareness date.  Information about lot and batch number was requested.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever; chills; headache; This is a spontaneous report from a contactable consumer. A 37-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration in left arm on 02Feb2021 at 01:30 PM at single dose for COVID-19 immunisation. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration in left arm on 12Jan2021 at 03:00 PM at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Patient did not take any other vaccine in four weeks. The patient was not pregnant at the time of vaccination. 05Jan2021, Patient was COVID tested after vaccination by nasal swab which revealed negative result. On 03Feb2021 at 01:00 AM, the patient experienced fever, chills and headache. No treatment was received. The outcome of the events was recovered.  Information on the batch/lot number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: False positive investigation result
Clinical narrative: I was supposed to get a contrast MRI next week (had the 1st COVID vaccine yesterday), to wait 21 days The clinic confirmed that they are getting false positives; This is a spontaneous report from a contactable consumer. An unknown patient of unspecified age and gender received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date were not provided) via unspecified route of administration on 08Feb2021 at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The Patient send the below link which said that if patient had a COVID vaccine patient must wait to get a mammogram because the vaccine causes swelling in the lymph nodes and the readouts give false positives. Patient was called at hospital and confirmed this information. In patient case where patient was supposed to get a contrast MRI next week (had the 1st COVID vaccine yesterday), to wait 21 days. The patient underwent lab test and procedure which included False positive investigation result was unknown result. The outcome of the event was unknown   Information on the lot/batch number has been requested.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Diagnosed with shingles; This is a spontaneous report from a contactable consumer. This male consumer (patient) reported for himself. A 75-year-male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN5318, Expiration date: unknown), via an unspecified route of administration in left arm on 24-JAN-2021 at 12:55 at single dose for COVID-19 immunization. The patient medical history was not reported. Patient concomitant included of unspecified flu shot, no further details provided about this medication. On 11Feb2021 patient diagnosed with shingles and prescribed Valtrex 1000 mg for shingles. patient wants to know if there was a contraindication for taking valtrex and getting the vaccine as well as having shingles and getting the vaccine. The outcome of event was unknown.   Follow-up (11Feb2021): This is a follow-up spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient).  Follow-up (11Feb2021): This is a follow-up spontaneous report from a contactable consumer. This 75-year-old consumer (patient) reported that:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Body aches starting 2/8 and ongoing Fatigue starting day of injection 2/6 and ongoing; Body aches starting 2/8 and ongoing Fatigue starting day of injection 2/6 and ongoing; This is a spontaneous report from a contactable consumer (patient). The 46-year-old non pregnant female patient received bnt162b2 (COMIRNATY, solution for injection, (Batch/Lot Number: EM9809) via intramuscular route of administration in right arm on 06Feb2021 at 01:45 PM as SINGLE DOSE for covid-19 immunization. Patient had other medical history of covid 19. The concomitant medication was not reported. On 06Feb2021 at 04:00 PM patient experienced body aches starting 2/8 and ongoing Fatigue starting day of injection 2/6 and ongoing. Patient received treatment of NSAIDs, Tylenol, caffeine and rest. Patient had known allergies. The outcome of the event was reported as recovering.
Sex: U
Vaccine: COVID19
Symptoms: HIV test, HIV test false positive, Maternal exposure timing unspecified
Clinical narrative: my daughter is in labor and they are talking about having to give her a C-section; mother is in labor; This is a spontaneous case received from a contactable consumer. It was reported, similar events for 2 patients (Mother and Foetus) and this is the second of two reports (Foetus). A 31-year-old of female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot Number: EN5318) as an unspecified dose for covid-19 immunizatioin. It was reported that, mother had COVID vaccine in last week and was in labor today, also done a rapid hiv test, which resulted false positive. Stated that, the medical staff were talking about having to give her a c-section. Mother underwent lab tests and procedures which included hiv test: positive, hiv test: unknown result on tested her again/currently waiting for test results. Reporter stated, wants to know if its is possible that, rapid HIV test got a false positive because of the received covid vaccine last week. The outcome for the events was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021129930 same drug, different patient and similar event
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Feeling abnormal, HLA-B*27 assay
Clinical narrative: I felt very tired verbatim/ exhausted; low energy; felt lousey for about 6-8 hours; This is a spontaneous report received from a contactable consumer (reporting on herself). A 77-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Formulation: solution for injection, Lot Number: EK9231and Expiration Date was not reported), via an unspecified route of administration in in Arm Left on 12Jan2021 12:00 as single dose for COVID-19 immunization. Medical history included, asthma, urticaria from an unknown date and unknown if ongoing , crohns disease all from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Historical vaccine includes first dose of BNT162B2 for covid-19 immunisation and experienced drug ineffective, covid-19 pneumonia, rash. The patient previously took cephalexine and experienced drug hypersensitivity. It was reported that when patient received her second injection, 2 was out of Quarantine for Covid. Also she asked  her doctor If she Should even both to have this injection because apparently she had had Covid pneumonia, through by 02Jan2021. She was feeling a lot better , she was advised by her doc to go ahead & have it., which she did. No problem from Noon when she got shot to Noon Next day, but after lunch ,felt very tired, exhausted & low energy, was very wcepcited, lay on the cover, went to bed early & woke up next day feeling fine. Test: Blood test for HLA-B27 had lite @ 3x the testing Date: 15 years ago Also 25 yrs ago Result: Yes always 3x Comment: This is for Ankylosing spondylitis, Crohn's disease, Citifies, All of which she have had, the as ongoing.The outcome of the events was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: I have had few side effects okay nothing drastic, joint pain; This is a spontaneous report from a contactable patient (patient herself). This 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL9261), via an unspecified route of administration on an unspecified date at single dose in her left arm for COVID-19 immunization. The patient's medical history was not reported. It was reported that the patient was taking a few other medications, and which were unspecified at the time of this report. On an unspecified date, patient stated that she got her vaccine on Saturday and she had few side effects okay nothing drastic. She had the vaccine, and she got these side effects. Patient just took an Advil for the little joint pain. The outcome of the event joint pain was unknown at the time of this report.   Information on the batch number has been requested.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain, Pyrexia
Clinical narrative: Chills; body aches; fever; nausea; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EL3247), via an unspecified route of administration in the left arm on 11Feb2021 at 08:45 AM (at the age of 60-year-old) as a single dose for COVID-19 immunization at Workplace clinic. Medical history included allergies to medications, food, or other products was Sulfa drugs. Prior to the vaccination, the patient was diagnosed with COVID-19. Patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications received within 2 weeks of vaccination included citalopram at 20 mg. Patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) for Covid-19 immunization. On 12Feb2021 at 12:00 AM, on the second day, the patient experienced chills, body aches, nausea and fever. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the chills, body aches, nausea and fever were recovering.  No follow-up attempts are Possible. No further information can be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure decreased, Blood pressure fluctuation, Blood pressure measurement, Dizziness
Clinical narrative: At 09:50 BP 157/98,then 09:51 BP 161/101, At 08:58 am 167/80,At 10:13 BP 181/93, At 10:22, BP 165/98,At 10:24 BP 164/102, At 10:27 BP 167/99; Unable to work after the 2nd dose; I wasn't able to go back to work because of severe weakness; Dizzy; my BP went down to 90/60, 80/56; This is a follow-up spontaneous report from a contactable Nurse in response to HCP letter sent in cross referenced case. A 49-years-old female patient received second dose of BNT162B2 (Solution for injection, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK9231) via an unspecified route of administration in deltoid right on 14Jan2021 at 09:00 (at age of 49 years old) as single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient's historical vaccine included first dose of BNT162B2 (Solution for injection, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730) via an unspecified route of administration on 20Dec2020 as single dose for Covid-19 immunization. On 14Jan2021, the patient was placed on close monitoring after receiving the second dose for continuous pulse oximetry, O2 saturations ranged from 98%-100%. At 09:50 BP 157/98, HR 73, 99% O2 sat, then 09:51 BP 161/101, HR 100, SpO2 100%, at 08:58 am 167/80, HR 85, SpO2 94%. The PCP prescribed clonidine 0.1 mg as needed for SBP>160. The patient took 1 tab clonidine 0.1mg. At 10:13 BP 181/93, HR 63, SPO2 100%, at 10:22, BP 165/98, HR 59, 100% SPO2, at 10:24 BP 164/102, HR 77, 99% SPO2, at 10:27 BP 167/99 HR 74, 100% SPO2. Later the patient took 2nd dose of clonidine 0.1mg and at 10:36 BP 134/86, HR 65, SPO2 100%, at 10:47 BP 124/81, HR 65. The patient was released by employee health nurse. She was dizzy when she got home, her BP went down to 90/60, 80/56. The patient was unable to work after second dose because of severe weakness. The patient stayed in bed for 5 days. The patient went back to work on 19Jan2021. Treatment for the event blood pressure fluctuation was two dose of tab clonidine 0.1mg. The patient provided information regarding the reported adverse events with the use of the suspect product to the nurse and the nurse considered that the Pfizer product had a causal effect to the adverse event. The outcome of the events was unknown.  Information on the batch number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Loss of personal independence in daily activities, Oxygen saturation
Clinical narrative: At 09:50 BP 157/98,then 09:51 BP 161/101, At 08:58 am 167/80,At 10:13 BP 181/93, At 10:22, BP 165/98,At 10:24 BP 164/102, At 10:27 BP 167/99; Unable to work after the 2nd dose; I wasn't able to go back to work because of severe weakness; Dizzy; my BP went down to 90/60, 80/56; This is a follow-up spontaneous report from a contactable Nurse in response to HCP letter sent in cross referenced case. A 49-years-old female patient received second dose of BNT162B2 (Solution for injection, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK9231) via an unspecified route of administration in deltoid right on 14Jan2021 at 09:00 (at age of 49 years old) as single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient's historical vaccine included first dose of BNT162B2 (Solution for injection, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730) via an unspecified route of administration on 20Dec2020 as single dose for Covid-19 immunization. On 14Jan2021, the patient was placed on close monitoring after receiving the second dose for continuous pulse oximetry, O2 saturations ranged from 98%-100%. At 09:50 BP 157/98, HR 73, 99% O2 sat, then 09:51 BP 161/101, HR 100, SpO2 100%, at 08:58 am 167/80, HR 85, SpO2 94%. The PCP prescribed clonidine 0.1 mg as needed for SBP>160. The patient took 1 tab clonidine 0.1mg. At 10:13 BP 181/93, HR 63, SPO2 100%, at 10:22, BP 165/98, HR 59, 100% SPO2, at 10:24 BP 164/102, HR 77, 99% SPO2, at 10:27 BP 167/99 HR 74, 100% SPO2. Later the patient took 2nd dose of clonidine 0.1mg and at 10:36 BP 134/86, HR 65, SPO2 100%, at 10:47 BP 124/81, HR 65. The patient was released by employee health nurse. She was dizzy when she got home, her BP went down to 90/60, 80/56. The patient was unable to work after second dose because of severe weakness. The patient stayed in bed for 5 days. The patient went back to work on 19Jan2021. Treatment for the event blood pressure fluctuation was two dose of tab clonidine 0.1mg. The patient provided information regarding the reported adverse events with the use of the suspect product to the nurse and the nurse considered that the Pfizer product had a causal effect to the adverse event. The outcome of the events was unknown.  Information on the batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: he and his wife won't be able to take the 2nd dose scheduled tomorrow because his wife was sick; This is a spontaneous report. A non-contactable consumer reported that a female patient of unspecified age received BNT162B2 (solution for injection, batch/lot no: unknown) via an unspecified route of administration on an unspecified date at single dose for covid 19 immunization. The patient's medical history and concomitant medications was not reported. On an unknown date, it was reported that he and his wife won't be able to take the 2nd dose scheduled tomorrow because his wife was sick. The outcome of the event was unknown.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Neck pain, Pain in extremity
Clinical narrative: neck and arm soreness; neck and arm soreness; L supraclavicular lymph nod swelling; This is a spontaneous report from a contactable other HCP (patient). A 35-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263) via unspecified route of administration in left arm on 27Jan2021, (at the age o f 35-years-old) as a single dose for COVID-19 immunisation. The patient medical history reported as non-chronic (not specified). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The concomitant medication was reported as none. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 09Feb2021, the patient Initially had neck and arm soreness 12 days post vaccine noted L supraclavicular lymph node swelling. The patient did not receive any treatment for the events. The outcome of the events was not resolved.
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Food poisoning, Hepatitis A virus test, Hepatitis A virus test positive, Infectious mononucleosis
Clinical narrative: positive result for Hepatitis A, Food Poisoning, and Mononucleosis; positive result for Hepatitis A, Food Poisoning, and Mononucleosis; positive result for Hepatitis A, Food Poisoning, and Mononucleosis; This is a spontaneous case report received from a contactable consumer(patient) via Pfizer-sponsored program. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on 09Feb2021 as a single dose for COVID-19 immunisation. Medical history included kidney transplant. The patient's concomitant medications were not reported. On unspecified date, the patient experienced hepatitis A virus test positive, food poisoning . He questioned if it was wrong of him to get vaccinated and get bloodwork done on the next day and if the vaccine may have caused this. The patient underwent lab tests and procedures which included blood test with unknown result, hepatitis A virus test positive. The clinical outcome of the events was unknown. Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body height, Weight
Clinical narrative: I develop pains, severe pain in my stomach; They come and go but not the severe is the pain that I had at 4 O' Clock; This is a spontaneous report received from a contactable consumer (patient). A 84-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9265; Expiration Date: 31Mar2021), via an unspecified route of administration on an unspecified date (at 9:05) as SINGLE DOSE (84 years at time of vaccination age) in left arm for covid-19 immunization. Medical history included: open heart surgery on 22Jan2018 and Quad surgery. The patient's concomitant medications were not reported. On 01Feb2021, the patient developed pains, severe pain in stomach at 4 O'clock this morning after the 5th day of bnt162b2 vaccination. They come and go but not the severe is the pain that he had at 4 O'clock. The patient was wondering is this normal and if it is when can he expect some relief from the stomach and if he could take to anything to elevate the pain. The patient did not receive any treatment for the event. The patient did not visit physician Office/ Emergency Room. The outcome of event stomach pain was recovered on an unspecified date 2021.  Information on the lot/batch number has been requested.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Inflammation, Pain, Skin lesion, Swelling
Clinical narrative: shingles in his forehead and close to his eye but not in eye; lesions; swelling, pain and inflammation; swelling, pain and inflammation; swelling, pain and inflammation; This is a spontaneous report from a contactable consumer. A 93-year-old male patient received the first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot number: EL3302), via unspecified route of administration on 22Jan2021 at 14:00 (at the age of 93-years-old) as a single dose for COVID-19 immunisation. It was reported that patient had a lot of medical conditions and takes a lot of medications (unspecified) (but nothing she thinks is related to the vaccine). Additional vaccines administered on same date of the pfizer suspect was none. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 07Feb2021 patient had lesions showed up and he was diagnosed with shingles he had symptoms 2-3 days prior: he was on a medical treatment with a viral medication, prednisone, ibuprofen and Tylenol. On Tuesday they went to see his ophthalmologist because he has shingles in his forehead and close to his eye but not in eye, his ophthalmologist said that after 10 days with the viral medication and 5 days with prednisone, he should be able to get the second dose of the vaccine. She would like to know if the vaccine could have caused him shingles. He was on a viral medication and was put on prednisone for swelling and inflammation on an unknown date in Feb2021. The patient was also alternating Tylenol and Advil for pain. The patient did not visit emergency room. The outcome of the events lesions, swelling, pain and inflammation was unknown while for shingles was not recovered.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrointestinal disorder, Nausea, Vomiting
Clinical narrative: GI issues; nausea; vomiting; This is a spontaneous report from a contactable consumer (patient wife) from a Pfizer-sponsored program, via medical information team. A 26 year old male patient (non-pregnant) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number EL9261) via an intramuscular route of administration on left arm, on 21Jan2021, 08:00 as single dose for covid-19 immunization. The patient had celiac disease as a medical history with gluten, kiwi, and penicillin allergies and concomitant medications were vortioxetine hydrobromide (TRINTELLIX), methylphenidate hydrochloride (RITALIN), Metformin. The patient previously took amoxicillin and had allergy. On 22Jan2021 the patient had GI issues, nausea, vomiting. The outcome of events was not recovered.   Follow-up attempts have been completed and no further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: Lost sense of taste and smell; Lost sense of taste and smell; This is a spontaneous report from a contactable other HCP (patient herself). An 50-year-old female patient non pregnant)received a first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number:EN6201 and expiration date: unknown) via intramuscular route of administration in left arm on 11Feb2021 at 09:00 AM as single dose for COVID-19 immunisation. The medical history included Depression and allergy to cephalosporins. Concomitant medications were not reported. Patient did not take any other vaccine in four weeks. No COVID prior vaccination and did not tested COVID post vaccination. On 11Feb2021 at 19:00, the patient experienced lost sense of taste and smell. The patient did not take any corrective treatment for the adverse event. The outcome of the events was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2
Clinical narrative: since had an exposure to a Covid-positive patient. She is in quarantine, and wants to know if she can still get her second dose as scheduled.; This is a spontaneous report from a contactable consumer or other non hcp (patient). A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported that since had an exposure to a COVID-positive patient. She was in quarantine and wanted to know if she can still get her second dose as scheduled. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Heart rate, Heart rate increased, Myalgia
Clinical narrative: fever at 102.6; Heart Rate 103; muscle/big joint pain; muscle/big joint pain; This is a spontaneous report from a contactable consumer (patient). A 55-years-old non pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 09Feb2021 09:30 (Batch/Lot Number: EL9265) as SINGLE DOSE (30mcg/0.3 mL) for covid-19 immunisation. Medical history included Type 2 Diabetes. Concomitant medication(s) included metformin (METFORMIN) taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 19Jan2021, 11:00 AM (Batch/Lot Number: EL3249) as SINGLE DOSE (30mcg/0.3 mL) for covid-19 immunisation. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. Known allergies was None. It was reported that the patient had fever at 102.6 Heart Rate 103, muscle/big joint pain 12th hr after 2nd dose on 09Feb2021 10:00 PM (22.00). fever reduced to 99.9F heart Rate 72 by 36th hr after vacinned, no muscle/joint pain temperature 98.6, heart rate 62 by 48 hr after. temperature 97.9 heart rate 66 by 72 hr after. No treatment received for AE. Outcome of the events was resolved in Feb2021.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever at 102.6; Heart Rate 103; muscle/big joint pain; muscle/big joint pain; This is a spontaneous report from a contactable consumer (patient). A 55-years-old non pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 09Feb2021 09:30 (Batch/Lot Number: EL9265) as SINGLE DOSE (30mcg/0.3 mL) for covid-19 immunisation. Medical history included Type 2 Diabetes. Concomitant medication(s) included metformin (METFORMIN) taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 19Jan2021, 11:00 AM (Batch/Lot Number: EL3249) as SINGLE DOSE (30mcg/0.3 mL) for covid-19 immunisation. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. Known allergies was None. It was reported that the patient had fever at 102.6 Heart Rate 103, muscle/big joint pain 12th hr after 2nd dose on 09Feb2021 10:00 PM (22.00). fever reduced to 99.9F heart Rate 72 by 36th hr after vacinned, no muscle/joint pain temperature 98.6, heart rate 62 by 48 hr after. temperature 97.9 heart rate 66 by 72 hr after. No treatment received for AE. Outcome of the events was resolved in Feb2021.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus- sudden onset with no prior events - 5 days after shot.; This is a spontaneous report from a contactable consumer (Patient).   A 72-year-old female (Non pregnant) patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, solution for injection, Lot number: el1283), via an unspecified route at left arm on 20Jan2021, 11:30 (Age at vaccination is 72 year), at SINGLE DOSE for COVID-19 immunisation. Medical history of the patient included low thyroid and patient was allergic to penicillin and iodine. Patient not received COVID prior vaccination. Patient concomitant medication included ibuprofen (Motrin) (medications in two weeks). Patient not received other vaccine in four weeks. On 25Jan2021, 07:00 AM (5 days after the shot), the patient had sudden onset of tinnitus, with no prior events. No treatment received for the event. Patient not tested COVID post vaccination. At the time of this report event outcome was not recovered.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Nausea, Pyrexia
Clinical narrative: she had a 102°F temperature/her temperature that went up to almost 102; headache/bad headache/horrible headache; nausea; chills; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6201), second dose via intramuscular in upper left arm on 09Feb2021 at 16:30 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (Lot number: EL3249) via intramuscular in upper left arm on 19Jan2021 at 17:30 as single dose for COVID-19 immunization. In Feb 2021, about 30 hours after the second vaccine, the patient experienced 102 degree Fahrenheit/her temperature that went up to almost 102, headache/bad headache/horrible headache, nausea and chills. The patient underwent lab test and procedures which included body temperature was 102 degree Fahrenheit. Therapeutic measures were taken as a result of the events include baby aspirin. Then three hours later she took two more baby aspirin and her temperature went down after each time she took aspirin, states everything went down after the aspirin, the chills, nausea, and headache went down. She was reading literature and it looks like by taking an aspirin she may have stopped the production of antibodies. She is asking if this is true and if she has to be revaccinated or what she has to do. By the time she stared to go to bed she started to get a headache. She clarified that all of her other symptoms started in the middle of the night the same day she received the second dose. By 11Feb2021, in the early morning around 01:30am or 04:30am (both of the times she took aspirin) she recovered from all the side effects except she still has a very slight temperature. By 09:00 on 11Feb2021, her temperature was down to 100 or 99. The outcome of the event pyrexia was recovering, and was recovered for headache, nausea and chills.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Ligament sprain, Movement disorder, Pain
Clinical narrative: Sprain in neck; hard to move my head; immense pain; This is a spontaneous report from a contactable other health professional (himself). A 39-years-old male patient received second dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247) via an unspecified route of administration, in arm left on 10Feb2021 14:00 as single dose for COVID-19 immunisation. The patient medical history and concomitant medication(s) included naproxen sodium (ALEVE). Patient did not take other vaccine in four weeks. Patient took other medications as a aleve in two weeks. On 12Feb2021 08:00 The patient experienced sprain in neck, hard to move my head and immense pain. Patient did not take treatment for events. Patient did not take vaccine prior to Covid and not tested post vaccination. The outcome of the events was not recovered.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at the injection site; This is a spontaneous report from a Pfizer Sponsored Program CEP 159558.  A male patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown), via an unspecified route of administration on 08Feb2021 at single dose for COVID-19 immunization. The patient medical history included covid-19.  The patient Concomitant medications were not reported. It was reported the patient got the vaccine yesterday. He felt warm but doesn't have a fever. Pain at the injection site and inquired if he can put the ice pack on the injection site, currently it's on his neck to cool him off. The patient had covid in dec and putting ice on his neck helped him before. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Body temperature, Fatigue, Listless
Clinical narrative: a bit achy, sore and achy during the night/left arm still sore; sore all over (joints, muscles, etc); sore all over (joints, muscles, etc); very tired/better but still tired; listless; fever of 100.3; left arm still sore and tender (esp on underside of upper arm)/generally fine but left arm still a bit tender,; bowels a bit different (as if I'd had a fever); This is a spontaneous report from a contactable Consumer. A 74-years-old female patient received second dose of BNT162B2 (solution for injection; (Batch/Lot Number: EN53181) via an unspecified route of administration, administered in left arm on 10Feb2021 at 08:30 as single dose for covid-19 immunisation. Medical history included atrial fibrillation, hypertension and Seasonal allergies. Concomitant medications included apixaban (ELIQUIS), diltiazem. Historical vaccine included BNT162B2 (product 1st Pfizer Covid shot; vaccine date: 20Jan2021; lot number: EL3246; vaccine location: Left arm) for covid-19 immunisation. The patient was not pregnant. Prior to vaccination, the patient was not tested for COVID-19. Since vaccination patient was not tested for covid-19. The patient experienced a bit achy, sore and achy during the night (1st day). On 2nd day she experienced sore all over (joints, muscles, etc), very tired, listless, fever of 100.3. On 3rd day better but still tired, left arm still sore and tender (esp on underside of upper arm). On 4th day generally fine but left arm still a bit tender, bowels a bit different (as if she did had a fever) and treatment was not received for the events. The patient underwent lab tests and procedures which included body temperature fever of 100.3. The outcome of the events was recovered.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pyrexia, Tenderness
Clinical narrative: a bit achy, sore and achy during the night/left arm still sore; sore all over (joints, muscles, etc); sore all over (joints, muscles, etc); very tired/better but still tired; listless; fever of 100.3; left arm still sore and tender (esp on underside of upper arm)/generally fine but left arm still a bit tender,; bowels a bit different (as if I'd had a fever); This is a spontaneous report from a contactable Consumer. A 74-years-old female patient received second dose of BNT162B2 (solution for injection; (Batch/Lot Number: EN53181) via an unspecified route of administration, administered in left arm on 10Feb2021 at 08:30 as single dose for covid-19 immunisation. Medical history included atrial fibrillation, hypertension and Seasonal allergies. Concomitant medications included apixaban (ELIQUIS), diltiazem. Historical vaccine included BNT162B2 (product 1st Pfizer Covid shot; vaccine date: 20Jan2021; lot number: EL3246; vaccine location: Left arm) for covid-19 immunisation. The patient was not pregnant. Prior to vaccination, the patient was not tested for COVID-19. Since vaccination patient was not tested for covid-19. The patient experienced a bit achy, sore and achy during the night (1st day). On 2nd day she experienced sore all over (joints, muscles, etc), very tired, listless, fever of 100.3. On 3rd day better but still tired, left arm still sore and tender (esp on underside of upper arm). On 4th day generally fine but left arm still a bit tender, bowels a bit different (as if she did had a fever) and treatment was not received for the events. The patient underwent lab tests and procedures which included body temperature fever of 100.3. The outcome of the events was recovered.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Myalgia, Pyrexia, Vomiting
Clinical narrative: fever of 101.3; full body muscle pain; headache; vomiting; This is a spontaneous report from a contactable consumer or other non hcp. A 66-year-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: Batch/Lot Number: 9809; Expiration Date: unknown) via an unspecified route of administration, in Arm Right on 09Feb2021 08:15 for COVID-19 immunization.The patient previously took first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: Batch/Lot Number: 3247; Expiration Date: unknown), via an unspecified route of administration, in Arm Right on 19Jan2021 08:15 for COVID-19 immunization. The patient previously took Levaquin and bnt162b2.Medical history included neuropathy peripheral, rosacea, drug hypersensitivity to levaquin. Concomitant medications included vitamins (MULTIPLE VITAMIN), ciclosporin (RESTASIS), calcium and omega 3 taken for an unspecified indication. The patient did not receive any other vaccines within 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Feb2021 22:00, the patient experienced fever of 101.3, full body muscle pain, headache, vomiting. The patient underwent lab tests and procedures which included body temperature: fever of 101.3 on 09Feb2021. The outcome of the event was recovered.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This is a spontaneous report from a contactable consumer. An 86-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot Number: EL9261) via an unspecified route of administration in left arm on 09Feb2021 at 11:45 as single dose for COVID-19 immunization. Medical history included 1 kidney removed and known allergies to Penicillin, Cephalosporins and Hazelnuts. Concomitant medication(s) included losartan, amlodipine, atorvastatin calcium and aspirin. Patient did not receive any other vaccines within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not diagnosed with COVID-19. On 11Feb2021 at 10:00, patient started having dizziness 48 hours after vaccine. Patient did not receive the treatment for events. The outcome of the events was recovered on an unspecified date of Feb2021.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia
Clinical narrative: Tiredness; Headache; Muscle ache; This is a spontaneous report from a contactable consumer (patient). A 62-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EN6201), via an unspecified route of administration in left arm on 11Feb2021 at 17:45 as single dose for COVID-19 immunization. The medical history of patient was included asthma, high blood pressure, obesity, allergies from Penicillin. Patient did not receive any other vaccine in four weeks. The concomitant medications of patient included triamterene, trazodone, citalopram and potassium (Other medications in two weeks). On 12Feb2021 at 06:00 AM, patient experienced tiredness, headache, muscle ache. Patient did not have COVID prior vaccination and also patient was not tested for COVID post vaccination. Patient did not receive any treatment. The outcome of event was recovering.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: 101.3  Fever; Fatigue; weakness; Pain at the injection site; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient re-ceived second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263), via an unspecified route of administration, administered in left arm on 12Feb2021 at 10:00 (at the age of 74 years old) as a single dose for COVID-19 immunisation. Medical history included Asthma, COPD, allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Con-comitant medications included for-moterol fumarate, mometasone furoate (DULERA), lisinopril, atorvastatin, albuterol and vitamin D. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took historical vaccine on first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3248) in left arm on 25Jan2021 at 10:00 for COVID-19 immunisation. On 12Feb2021 at 20:00 the patient experienced 101.3 fever, fatigue, weakness and pain at the injection site. The patient did not receive any treatment for the events. The patient underwent lab tests and procedures which included body temperature 101.3 on 12Feb2021. The outcome of the events was recovering.